You are here: Industry Insights > Oklahoma

News List

Oklahoma supreme court overturns ruling against J&J in $465m opioid lawsuit Pharmaceutical-Technology
November 11, 2021
The Oklahoma State Supreme Court in the US has overturned a 2019 judgement that had ruled Johnson & Johnson (J&J) and its Janssen Pharmaceutical Companies accountable for contributing to the opioid crisis.
Endo agrees opioid settlement payment with Oklahoma for $8.75m europeanpharmaceuticalreview
January 15, 2020
The US state of Oklahoma has agreed to a settlement from Endo International after an investigation into its role in the opioid abuse crisis.
J&J ordered to pay $572m to Oklahoma over opioid crisis europeanpharmaceuticalreview
August 29, 2019
The pharmaceutical company is planning to appeal the decision to pay the state for damages relating to the US opioid crisis.
Oklahoma Judge Fines Johnson & Johnson $572 Billion Over Opioid Drug Crisis drugs
August 27, 2019
An Oklahoma judge on Monday ruled against one of America's biggest companies, Johnson & Johnson -- fining it $572 million as part of the first trial of an opioid maker sued by...
Oklahoma seeks $17bn from J&J for opioid crisis pharmaceutical-technology
July 17, 2019
Lawyers for the US state of Oklahoma have argued that Johnson & Johnson (J&J) should be held responsible for driving opioid epidemic in the country and pay around $17bn over 30 years to address the crisis.
$85 million settlement agreed for opioid case in Oklahoma europeanpharmaceuticalreview
May 30, 2019
Teva has agreed to pay Oklahoma, resolving allegations that illegal marketing of its medication contributed to the state’s opioid epidemic.
Teva agrees to $85m settlement in Oklahoma opioid case pharmaceutical-technology
May 29, 2019
Teva Pharmaceutical has agreed to pay $85m to Oklahoma, resolving allegations that illegal marketing of the company’s pain medication contributed to the US state’s opioid epidemic.
After Oklahoma payout, Purdue faces 5 new state lawsuits over OxyContin fiercepharma
May 21, 2019
Purdue Pharma and its founding family took a quarter-of-a-billion-dollar hit when it settled with the state of Oklahoma over a lawsuit accusing the company of pushing false and misleading ads for powerful opioid OxyContin.
Purdue agrees to pay $270 million to Oklahoma to resolve OxyContin lawsuit firstwordpharma
March 27, 2019
Purdue Pharma agreed on Tuesday to pay about $270 million to Oklahoma to resolve allegations that the drugmaker fuelled the opioid crisis through its aggressive marketing of OxyContin (oxycodone).